Role of standards and funding in accelerating the development and use of microphysiological systems
Main Article Content
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).
Bachal, K., Yadav, S., Gandhi, P. et al. (2023). Design and validation of a flowless gradient generating microfluidic device for high-throughput drug testing. Lab Chip 23, 261-271. doi:10.1039/d2lc00879c
Baudy, A. R., Otieno, M. A., Hewitt, P. et al. (2020). Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry. Lab Chip 20, 215-225. doi:10.1039/c9lc00768g
Ewart, L. and Roth, A. (2021). Opportunities and challenges with microphysiological systems: A pharma end-user perspective. Nat Rev Drug Discov 20, 327-328. doi:10.1038/d41573-020-00030-2
Ewart, L., Apostolou, A., Briggs, S. A. et al. (2022). Performance assessment and economic analysis of a human liver-chip for predictive toxicology. Commun Med 2, 154. doi:10.1038/s43856-022-00209-1
Pamies, D., Ekert, J., Zurich, M. G. et al. (2024). Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility. Stem Cell Rep 19, 604-617. doi:10.1016/j.stemcr.2024.03.009